Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 139 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1672. Clear
Clear
Q1
AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View → Q1
AVENUE SOLUTIONS for MERCK & CO. INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View → Q1
TODD STRATEGY GROUP for NOVARTIS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View → Q1
BGR GOVERNMENT AFFAIRS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View → Q1
NOVARTIS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q1
TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View → Q1
TODD STRATEGY GROUP for ALEXION PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $80,000.00 income
Medicare/Medicaid, Health Issues
View → Q1
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $20,000.00 income
Health Issues, Medicare/Medicaid
View → Q1
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $30,000.00 income
Medicare/Medicaid
View → Q1
TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View → Q1
TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View → Q1
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View → Q1
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Health Issues
View → Q1
PUBLIC CITIZEN for PUBLIC CITIZEN
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Banking, Budget/Appropriations, Civil Rights/Civil Liberties, Consumer Issues/Safety/Products
View →
Previous Page 6 of 6

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem